These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22814631)

  • 1. Implantable cardiovascular sensors and computers: interventional heart failure strategies.
    Smith SA; Abraham WT
    Curr Cardiol Rep; 2012 Oct; 14(5):611-8. PubMed ID: 22814631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Device therapy in advanced heart failure: what to put in and what to turn off: remote telemonitoring and implantable hemodynamic devices for advanced heart failure monitoring in the ambulatory setting and the evolving role of cardiac resynchronization therapy.
    Smith SA; Abraham WT
    Congest Heart Fail; 2011; 17(5):220-6. PubMed ID: 21906246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable Cardiovascular Devices: Current and Emerging Technologies for Remote Heart Failure Monitoring.
    Gill J
    Cardiol Rev; 2023 May-Jun 01; 31(3):128-138. PubMed ID: 35349243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators: Current Status and Future Needs.
    Theuns DAMJ; Radhoe SP; Brugts JJ
    Sensors (Basel); 2021 May; 21(11):. PubMed ID: 34071624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic power and healthcare resource consumption of a dedicated workflow algorithm designed to manage thoracic impedance alerts in heart failure patients by remote monitoring.
    Ricci RP; Morichelli L; Porfili A; Quarta L; Sassi A
    J Cardiovasc Med (Hagerstown); 2018 Mar; 19(3):105-112. PubMed ID: 29283915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fundamentals of intrathoracic impedance monitoring in heart failure.
    Wang L
    Am J Cardiol; 2007 May; 99(10A):3G-10G. PubMed ID: 17512421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease management: remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and haemodynamic monitors.
    Abraham WT
    Europace; 2013 Jun; 15 Suppl 1():i40-i46. PubMed ID: 23737229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telemonitoring in chronic heart failure.
    Hasan A; Paul V
    Eur Heart J; 2011 Jun; 32(12):1457-64. PubMed ID: 21289040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Device monitoring of heart failure in cardiac resynchronization therapy device recipients: a single-center experience with a novel multivector impedance monitoring system.
    Forleo GB; Panattoni G; Schirripa V; Papavasileiou LP; Della Rocca DG; Politano A; Ticconi F; Biscione C; Sergi D; Di Molfetta A; Santini L; Capria A; Romeo F
    J Cardiovasc Med (Hagerstown); 2013 Oct; 14(10):726-32. PubMed ID: 23996011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Device diagnostics and early identification of acute decompensated heart failure: a systematic review.
    Blair TL
    J Cardiovasc Nurs; 2014; 29(1):68-81. PubMed ID: 23369854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracardiac impedance after cardiac resynchronization therapy is a novel predictor for worsening of heart failure.
    Suzuki H; Nodera M; Kamioka M; Kaneshiro T; Kamiyama Y; Takeishi Y
    Heart Vessels; 2017 Aug; 32(8):926-931. PubMed ID: 28181011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory Monitoring of Heart Sounds via an Implanted Device Is Superior to Auscultation for Prediction of Heart Failure Events.
    Cao M; Gardner RS; Hariharan R; Nair DG; Schulze C; An Q; Thakur PH; Kwan B; Zhang Y; Boehmer JP
    J Card Fail; 2020 Feb; 26(2):151-159. PubMed ID: 31634574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New diagnostic devices in heart failure.
    Schlendorf KH; Russell SD
    Curr Opin Cardiol; 2010 May; 25(3):262-7. PubMed ID: 20308889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T.M.I. (Too much information)?
    Udelson JE
    Circulation; 2011 Oct; 124(16):1697-9. PubMed ID: 21931082
    [No Abstract]   [Full Text] [Related]  

  • 15. Monitoring of Daily Body Weight and Intrathoracic Impedance in Heart Failure Patients With a High Risk of Volume Overload Decompensation.
    Gudmundsson K; Lyngå P; Rosenqvist M; Braunschweig F
    Clin Cardiol; 2016 Aug; 39(8):446-52. PubMed ID: 27175605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable Hemodynamic-GUIDE Monitors: A CHAMPION Among Devices for Heart Failure.
    Fudim M; Butler J; Kittipibul V
    J Am Coll Cardiol; 2024 Feb; 83(6):695-698. PubMed ID: 38325995
    [No Abstract]   [Full Text] [Related]  

  • 17. Predicting heart failure decompensation using cardiac implantable electronic devices: a review of practices and challenges.
    Hawkins NM; Virani SA; Sperrin M; Buchan IE; McMurray JJ; Krahn AD
    Eur J Heart Fail; 2016 Aug; 18(8):977-86. PubMed ID: 26663507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OptiVol fluid index: does an association with ventricular arrhythmias hold water?
    Sullivan RM; Olshansky B
    J Cardiovasc Electrophysiol; 2011 Mar; 22(3):300-1. PubMed ID: 21091968
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.
    van Veldhuisen DJ; Braunschweig F; Conraads V; Ford I; Cowie MR; Jondeau G; Kautzner J; Aguilera RM; Lunati M; Yu CM; Gerritse B; Borggrefe M;
    Circulation; 2011 Oct; 124(16):1719-26. PubMed ID: 21931078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable Hemodynamic Monitoring in Ambulatory Heart Failure: Who, When, Why, How?
    Desai AS
    Curr Cardiol Rep; 2015 Dec; 17(12):113. PubMed ID: 26482756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.